1. P013 Role of IL-36RA mutations in Crohn's disease. (30th January 2023) Authors: Hecker, J; Saurenbach, J; Letizia, M; Löscher, B S; Franke, A; Kühl, A A; Atreya, R; Koop, K; Neufert, C; Trajanoski, Z; Schütz, A; Siegmund, B; Weidinger, C Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P03.31 Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. (1st October 2020) Authors: Prokopi, N; Tripp, CH; Tummers, B; Crawford, JC; Efremova, M; Hutter, K; Bellmann, L; Cappellano, G; Boon, L; Ortner, D; Trajanoski, Z; Chen, S; de Gruijl, T; Green, DR; Stoitzner, P Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P068 Polyunsaturated fatty acid excess fuels pro-inflammatory transcriptional networks in GPX4 deficient intestinal epithelial cells. (30th January 2023) Authors: Meyer, M; Grabherr, F; Schwärzler, J; Mayr, L; Jukic, A; Rao, Z; Rieder, D; Zollner, A; Grander, C; Trajanoski, Z; Koeberle, A; Tilg, H; Adolph, T E Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P247 Oncostatin M and its receptor are markers of endoscopic and histological disease activity in Inflammatory Bowel Disease. (30th January 2023) Authors: Nguyen, A; Sturm, G; Plattner, C; Trajanoski, Z; Atreya, R; IBDome Consortium, I C; Siegmund, B; Hegazy, A N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗